These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5685936)

  • 1. [Damage to the liver parenchyma induced by desferrioxamine B therapy].
    Schmidt UJ; Brüschke G; Kranz D; Haase J; Ihle R
    Dtsch Gesundheitsw; 1968 Aug; 23(33):1542-4. PubMed ID: 5685936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver parenchyma damage by treatment with desferrioxamine B].
    Schmidt UJ; Kranz D; Brüschke G; Kalbe I; Rürup B
    Dtsch Gesundheitsw; 1969 May; 24(21):995-6. PubMed ID: 5385364
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of desferrioxamine B. A new iron eliminating agent, on cases of secondary haemosiderosis in children.
    el-Gholmy A; Khalifa AS; Rahman YA; el-Bagoury I
    J Trop Med Hyg; 1969 Jan; 72(1):22-6. PubMed ID: 5773810
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
    Kirimlidis S; Philippidis P; Drossos C; Economidis J
    Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
    Sidi Y; Shaklai M; Liban E; Pinkhas J
    Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
    Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
    Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
    Kaung DT
    J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis and therapy of iron overload with desferrioxamine].
    Andres J; Stobbe H
    Z Gesamte Inn Med; 1984 Apr; 39(8):167-9. PubMed ID: 6730593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hemodialysis hemosiderosis with desferrioxamine.
    Rembold CM; Krumlovsky FA; Roxe DM; Fitzsimmons E; del Greco F
    Trans Am Soc Artif Intern Organs; 1982; 28():621-6. PubMed ID: 7164314
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
    Hildner FJ; Monto RW; Rebuck JW
    Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hemosiderosis with deferoxamine].
    Strohmeyer G; Stremmel W
    Dtsch Med Wochenschr; 1984 Nov; 109(44):1669-70. PubMed ID: 6489179
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of desferrioxamine in iron poisoning and hemosiderosis].
    Karlsson B; Lagercrantz R; Brann I; Strandberg O; Reizenstein P
    Nord Med; 1965 Oct; 74(40):985-8. PubMed ID: 5836665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
    Maspes V; Tamigaki M; Gomes ZJ; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in iron chelation therapy.
    Cario H; Janka-Schaub G; Janssen G; Jarisch A; Strauss G; Kohne E
    Klin Padiatr; 2007; 219(3):158-65. PubMed ID: 17525910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iron-chelating treatment].
    Vullo C; Di Palma A; De Sanctis V; Borgatti L; Atti G
    Haematologica; 1989 Oct; 74(5 Suppl):241-51. PubMed ID: 2512211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
    Muranda M; Velasco M; Giménez E; Ruiz J; Bastías E; Rodriguez J; Etcheverry R; Guzmán C; Regonesi C; Janklevich S
    Rev Med Chil; 1965 Apr; 93(4):127-33. PubMed ID: 5832943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
    Tillmann W; König R; Schröder K; Schröter W
    Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
    [No Abstract]   [Full Text] [Related]  

  • 20. [Continuous subcutaneous deferoxamine treatment in thalassemia major. Decrease of hemosiderosis and improvement of liver function].
    Krüger N; Ullrich D; Tillmann W; Schröter W
    Dtsch Med Wochenschr; 1985 Nov; 110(48):1848-51. PubMed ID: 4064938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.